NeelimaVidulaMD

PubMed

• Genomic spectrum of actionable alterations in serial cell free DNA (cfDNA) analysis of patients with metastatic breast cancer.
  Yael Bar, Jennifer C Keenan, Andrzej Niemierko, Arielle J Medford, Steven J Isakoff, Leif W Ellisen, Aditya Bardia, Neelima Vidula> ;NPJ Breast Cancer. 2024 Apr 11
• Selection of appropriate biomarkers to monitor effectiveness of ovarian function suppression in pre-menopausal patients with ER+ breast cancer.
  McCann, K., Regan, M., Goldfarb, S., Traina, T., Vidula, N., Kaklamani, V.> ;NPJ Breast Cancer. 2024 Jan 19
• -The Benefits and Challenges of Completing Standardized Staging Modules.
  Neelima Vidula, Jeffrey Peppercorn> ;JCO Oncology Practice. 2023 Oct 1
• Glutaminase (GLS1) gene expression in primary breast cancer.
  Neelima Vidula, Christina Yau, Hope S Rugo> ;Breast Cancer. 2023 Nov 1
• Utilizing cell-free DNA to predict risk of developing brain metastases in patients with metastatic breast cancer.
  Neelima Vidula, Andrzej Niemierko, Katherine Hesler, Lianne Ryan, Beverly Moy, Steven Isakoff, Leif Ellisen, Dejan Juric, Aditya Bardia> ;NPJ Breast Cancer. 2023 Apr 19
• Arrhythmogenic Cardiotoxicity Associated With Contemporary Treatments of Lymphoproliferative Disorders.
  Saadia Sherazi, Susan Schleede, Scott McNitt, Carla Casulo, Jeremiah E Moore, Eugene Storozynsky, Arpan Patel, Neelima Vidula, Mehmet K Aktas, Clive S Zent, Ilan Golde...> ;Journal of the American Heart Association. 2023 Mar 21
• 2 citations
  Detection of microsatellite instability high (MSI-H) status by targeted plasma-based genotyping in metastatic breast cancer.
  Neelima Vidula, Andrew Lipman, Shumei Kato, Caroline Weipert, Katherine Hesler, Georges Azzi, Ahmed Elkhanany, Dejan Juric, Estelamari Rodriguez, Colleen Faulkner, Pau...> ;NPJ Breast Cancer. 2022 Nov 4
• 8 citations
  Trophoblast Cell Surface Antigen 2 gene (TACSTD2) expression in primary breast cancer.
  Neelima Vidula, Christina Yau, Hope Rugo> ;Breast Cancer Research and Treatment. 2022 Aug 1
• 2 citations
  Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer.
  Elyssa Denault, Erika Nakajima, Vivek Naranbhai, Jennifer A Hutchinson, Lindsey Mortensen, Elizabeth Neihoff, Caroline Barabell, Amy Comander, Dejan Juric, Irene Kuter...> ;Therapeutic Advances in Medical Oncology. 2022 Jan 1
• 8 citations
  Evaluation of disseminated tumor cells and circulating tumor cells in patients with breast cancer receiving adjuvant zoledronic acid.
  Neelima Vidula, Sarah L M Greenberg, Laura A. Petrillo, Jimmy Hwang, Michelle E. Melisko, Andrei Goga, Mark M. Moasser, Mark Jesus M. Magbanua, John W. Park, Hope S. Rugo> ;NPJ Breast Cancer. 2021 Sep 6
• 17 citations
  NTRK1 Fusions identified by non-invasive plasma next-generation sequencing (NGS) across 9 cancer types
  Christian Rolfo, Alexander Drilon, David S. Hong, Caroline E. McCoach, Afshin Dowlati, Jessica J. Lin, Alessandro Russo, Alison M. Schram, Stephen V. Liu, Jorge Nieva,...> ;British Journal of Cancer. 2021 Sep 3
• 8 citations
  A First-in-Human Phase 1 Study of a Novel Selective Androgen Receptor Modulator (SARM), RAD140, in ER+/HER2- Metastatic Breast Cancer.
  Patricia LoRusso, Erika Hamilton, Cynthia X. Ma, Neelima Vidula, Rebecca G. Bagley, Steven Troy, Miriam Annett, Ziyang Yu, Maureen G. Conlan, Amy Weise> ;Clinical Breast Cancer. 2021 Aug 20
• 12 citations
  Novel Therapies for Metastatic Triple-Negative Breast Cancer: Spotlight on Immunotherapy and Antibody-Drug Conjugates.
  Aiko Nagayama, Neelima Vidula, Aditya Bardia> ;Oncology. 2021 May 13
• 8 citations
  Programmed cell death 1 (PD-1) receptor and programmed death ligand 1 (PD-L1) gene expression in primary breast cancer.
  Neelima Vidula, Christina Yau, Hope S. Rugo> ;Breast Cancer Research and Treatment. 2021 Apr 28
• 37 citations
  Clinical Outcomes With Abemaciclib After Prior CDK4/6 Inhibitor Progression in Breast Cancer: A Multicenter Experience.
  Seth A. Wander, Hyo S. Han, Mark L. Zangardi, Andrzej Niemierko, Veronica Mariotti, Leslie S L Kim, Jing Xi, Apurva Pandey, Siobhan Dunne, Azadeh Nasrazadani, Avinash ...> ;Journal of the National Comprehensive Cancer Network. 2021 Mar 24
• 9 citations
  Tumor Tissue- versus Plasma-based Genotyping for Selection of Matched Therapy and Impact on Clinical Outcomes in Patients with Metastatic Breast Cancer.
  Neelima Vidula, Andrzej Niemierko, Giuliana Malvarosa, Megan Yuen, Jochen K. Lennerz, A. John Iafrate, Seth A. Wander, Laura Spring, Dejan Juric, Steven J. Isakoff, Je...> ;Clinical Cancer Research. 2021 Jan 27
• 1 citations
  Clinical application of liquid biopsies to detect somatic BRCA1/2 mutations and guide potential therapeutic intervention for patients with metastatic breast cancer.
  Neelima Vidula, Leif W. Ellisen, Aditya Bardia> ;Oncotarget. 2021 Jan 19
• 7 citations
  Novel Agents for Metastatic Triple-Negative Breast Cancer: Finding the Positive in the Negative
  Neelima Vidula, Leif W. Ellisen, Aditya Bardia> ;Journal of the National Comprehensive Cancer Network. 2021 Jan 6
• 12 citations
  Rising Circulating Tumor DNA As a Molecular Biomarker of Early Disease Progression in Metastatic Breast Cancer
  Marko Velimirovic, Dejan Juric, Andrzej Niemierko, Laura Spring, Neelima Vidula, Seth A. Wander, Arielle Medford, Aparna Raj Parikh, Giuliana Malvarosa, Megan Yuen, Ry...> ;JCO Precision Oncology. 2020 Oct 19
• 65 citations
  Novel antibody–drug conjugates for triple negative breast cancer:
  Aiko Nagayama, Neelima Vidula, Leif W. Ellisen, Aditya Bardia> ;Therapeutic Advances in Medical Oncology. 2020 May 11
• 28 citations
  Routine Plasma-Based Genotyping to Comprehensively Detect Germline, Somatic, and Reversion BRCA Mutations among Patients with Advanced Solid Tumors
  , , , , , , , , , , , , , , , , , , , > ;Clinical Cancer Research. 2020 Feb 7
• 10 citations
  Identification of somatically acquired BRCA1/2 mutations by cfDNA analysis in patients with metastatic breast cancer
  Neelima Vidula, Taronish D. Dubash, Michael S. Lawrence, Antoine Simoneau, Andrzej Niemierko, Erica Blouch, Becky Nagy, Whijae Roh, Brian Chirn, Brittany A. Reeves, Gi...> ;Clinical Cancer Research. 2020 Sep 15
• 46 citations
  FGFR1 Amplification Mediates Endocrine Resistance but Retains TORC Sensitivity in Metastatic Hormone Receptor-Positive (HR+) Breast Cancer.
  Joshua Z. Drago, Luigi Formisano, Dejan Juric, Andrzej Niemierko, Alberto Servetto, Seth A. Wander, Laura Spring, Neelima Vidula, Jerry Younger, Jeffrey Peppercorn, Me...> ;Clinical Cancer Research. 2019 Nov 1
• 23 citations
  Blood-based monitoring identifies acquired and targetable driver HER2 mutations in endocrine-resistant metastatic breast cancer
  Arielle Medford, Taronish D. Dubash, Dejan Juric, Laura Spring, Andrzej Niemierko, Neelima Vidula, Jeffrey Peppercorn, Steven J. Isakoff, Brittany A. Reeves, Joseph A....> ;NPJ Precision Oncology. 2019 Jul 16
• Androgen receptor gene expression in primary breast cancer.
  Neelima Vidula, Christina Yau, Denise Wolf, Hope S Rugo> ;NPJ Breast Cancer. 2019 Jan 1
• Join now to see all

Lectures

• Glutaminase (GLS) expression in primary breast cancer (BC): Correlations with clinical and tumor characteristics. 
  2019 ASCO Annual Meeting - 6/1/2019
• A randomized phase II study of pembrolizumab, an anti-PD (programmed cell death) 1 antibody, in combination with carboplatin compared to carboplatin alone in breast ca... 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
• Comparison of tissue genotyping (TG) vs circulating tumor DNA (ctDNA) for selection of matched therapy and impact on clinical outcomes among patients with metastatic b... 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018